Survival in early lung cancer patients treated with high dose radiotherapy is independent of pathological confirmation

MLA

Franz Zehentmayr, et al. “Survival in Early Lung Cancer Patients Treated with High Dose Radiotherapy Is Independent of Pathological Confirmation.” Thoracic Cancer, vol. 10, no. 2, Feb. 2019, pp. 321–29. EBSCOhost, https://doi.org/10.1111/1759-7714.12966.

APA

Franz Zehentmayr, Martin Sprenger, Lukas Rettenbacher, Romana Wass, Peter Porsch, Gerd Fastner, Christian Pirich, Michael Studnicka, & Felix Sedlmayer. (2019). Survival in early lung cancer patients treated with high dose radiotherapy is independent of pathological confirmation. Thoracic Cancer, 10(2), 321–329. https://doi.org/10.1111/1759-7714.12966

Chicago

Franz Zehentmayr, Martin Sprenger, Lukas Rettenbacher, Romana Wass, Peter Porsch, Gerd Fastner, Christian Pirich, Michael Studnicka, and Felix Sedlmayer. 2019. “Survival in Early Lung Cancer Patients Treated with High Dose Radiotherapy Is Independent of Pathological Confirmation.” Thoracic Cancer 10 (2): 321–29. doi:10.1111/1759-7714.12966.